Skip to main content
Erschienen in: Netherlands Heart Journal 7-8/2015

Open Access 01.07.2015 | Editor’s Comment

ECG screening in athletes: optional or mandatory?

verfasst von: E. E. van der Wall

Erschienen in: Netherlands Heart Journal | Ausgabe 7-8/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
In April 2015, it was reported by the San Antonio Express-News (Texas, USA) that legislation, requiring that high school student athletes should undergo electrocardiographic (ECG) screening before participating in sports, passed with a clear majority through a second reading in the Texas House. At the same time, The Dallas Morning News pointed out that the American College of Cardiology (ACC) and the Texas Pediatric Society were against the measure.
There are few topics that lead to more controversy amongst physicians caring for young athletes than the correct method of pre-participation physical screening. On one hand, there is the conviction that physical screening has limited use if the end result is the final common pathway, that is unstable ventricular arrhythmias [1]; on the other hand, there is the belief that all young athletes, regardless of the sport and level of participation, require history, physical examination, (stress) ECG, echocardiography and, if necessary, even magnetic resonance imaging and computed tomography [2, 3].
What fuels such debates is the fact that sudden cardiac death (SCD) in the young athlete is estimated to occur in between 0.5 and 1 per 100,000 participating athletes below the age of 35 years [4]. In the USA, 50–75 deaths per year occur in young athletes; in France, this is approximately 10–15 [5]. Although these are very low numbers, it should be realised that competitive young male athletes suffer a fivefold higher risk of sudden cardiac death than non-competitive athletes, and male athletes aged more than 30 years bear a potential for arrhythmias, atrial fibrillation or a 20-fold higher possibility of SCD than female athletes. Ruwald et al. [6] showed recently in the European Heart Journal (EHJ, April 2015) that competitive sport is associated with a twofold increased risk of ventricular arrhythmias/death when compared with inactive patients and with patients who participated in recreational sport. When compared with inactive patients, recreational sport was not associated with an earlier onset of symptoms or increased risk of ventricular arrhythmias/death. Therefore, the question arises how to prevent these events in competitive sports, even if they are relatively rare. Do these events justify the use of all our medical armamentarium, in particular, an ECG or even an exercise ECG?
In Italy in 2006, Corrado et al. [7] were able to show a reduction in the incidence of sudden cardiac death due to the screening intervention and appropriate restriction of athletes with arrhythmogenic right ventricular dysplasia. Can these results be extrapolated to other countries [8]? Perhaps it is best to focus on some achievable goals in pre-participation screening: (1) identify individuals known to be at risk and allow stratification of these risks, and (2) make recommendations regarding participation.
In 2011, the Journal of the American College of Cardiology (JACC) featured an article entitled ‘Mandatory Electrocardiographic Screening of Athletes to Reduce Their Risk for Sudden Death: Proven Fact or Wishful Thinking?’, which suggests the latter [9]. The study analysed the incidence of sudden death among competitive athletes following the enactment of the 1997 USA National Sport Law, which mandates screening of all athletes with resting ECG and exercise testing. The average yearly incidence of sudden death or cardiac arrest events was 2.6 events per 100,000 athlete-years. The study concluded that mandatory ECG screening of athletes had no apparent effect on their risk of cardiac arrest. The authors suggested that the higher incidence of sudden death found in the Italian studies was not representative of the sudden death risk in the athlete population of most other countries and continents, which have a much lower incidence.
When considering the current guidelines and recommendations, there is a disparity between Europe and the USA regarding the advice one should follow. Both the ACC and the American Heart Association (AHA) still agree that the mandatory screening of all young athletes with an ECG is not warranted based on cost due to the large number of tests that would be required, the low incidence of sudden death among athletes in the USA as well as the concern for false-positive results. Proceedings of the ACC Sports and Exercise Cardiology Think Tank, Washington, DC, on 18 October 2012 (published in JACC, November 2014), reported that, before changes in screening programs are recommended in the USA, data should be acquired that can demonstrate an improved outcome in young, asymptomatic athletes and show that the benefit of screening outweighs the risks [10]. By contrast, both the European Society of Cardiology (ESC) and the International Olympic Committee (IOC) have an opposing view and recommend resting electrocardiograms for all young athletes before they are allowed to compete [11]. The ESC and IOC points of view appear to now be in line with the recent legislation bill in Texas, USA, requiring that high school students should undergo ECG screening before participating in sports.
This verdict is corroborated by a recent study from Leischik et al. [12] stating that there is a basic need for indicated examinations and/or preventive measures inside or outside of pre-competition screening, both for young and older athletes (< 35 and > 35 years). Competitive ambitious athletes < 35 years should undergo a specific cardiological examination including echocardiography and exercise test, and regular annual check-up examinations if problems occur and before starting a training session. This policy largely supports the Lausanne protocol (revised in 2013), followed by our national Society of Sports Medicine (VSG), advocating a 12-lead resting ECG in ‘top sportsmen’ < 35 years of age (http://​www.​sportgeneeskunde​.​com/​richtlijnen-vsg). Athletes > 30 years of age, undergoing extreme endurance competition, for example, triathlon or marathon, should preferably be examined by stress echocardiography from a prognostic point of view [13]. According to the authors [12], the costs for screening examinations should be regarded as negligible, given the high expenditures for preparation and participation in marathon and triathlon competitions or intensive costs in professional football and other team sports. Prevention of sudden sport-related deaths does not only have an individual component, but also a significant social impact on physical activity in the general population. In this regard, further expenses, studies and well-founded pre-competition screening in the industrialised world are socially justified and financially reasonable. The authors clearly affirm that the long-lasting disputes about using resting-ECG in pre-competitive sport screening belong to the past and that exercise tests should not only be reserved for professional teams.
To conclude, recent strategies, in particular based on European studies, seem to be in favour of routinely performing ECG screening in all athletes involved in competitive sports activities, irrespective of age and (family) history. This policy has, of course, the necessary implications for the present pre-participation screening. To further improve pre-participation screening, a dedicated education and certification program on 12-lead ECG interpretation is needed [14, 15]. Standardised screening tools that include screening and interpretation of both resting and exercise ECGs for targeted athlete populations at risk of SCD are required [16]. These recommendations are aimed to overcome the resistance raised by individuals and institutions to pre-participation screening with an ECG.
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
3.
Zurück zum Zitat Braber TL, Mosterd A, Prakken NH, et al. Rationale and design of the Measuring Athlete’s Risk of Cardiovascular events (MARC) study: the role of coronary CT in the cardiovascular evaluation of middle-aged sportsmen. Neth Heart J. 2015;23:133–8. doi:10.1007/s12471-014-0630-0.PubMedCentralPubMedCrossRef Braber TL, Mosterd A, Prakken NH, et al. Rationale and design of the Measuring Athlete’s Risk of Cardiovascular events (MARC) study: the role of coronary CT in the cardiovascular evaluation of middle-aged sportsmen. Neth Heart J. 2015;23:133–8. doi:10.1007/s12471-014-0630-0.PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Beus MF de. Sudden cardiac events in athletes. The SPORTCOR initiative [PhD thesis]. Utrecht (The Netherlands): University of Utrecht; 2010. Beus MF de. Sudden cardiac events in athletes. The SPORTCOR initiative [PhD thesis]. Utrecht (The Netherlands): University of Utrecht; 2010.
5.
Zurück zum Zitat Marijon E, Tafflet M, Celermajer DS, et al. Sports-related sudden death in the general population. Circulation. 2011;124:672–81.PubMedCrossRef Marijon E, Tafflet M, Celermajer DS, et al. Sports-related sudden death in the general population. Circulation. 2011;124:672–81.PubMedCrossRef
6.
Zurück zum Zitat Ruwald AC, Marcus F, Estes NA 3rd, et al. Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2015 April 20. pii:ehv110. Epub ahead of print. Ruwald AC, Marcus F, Estes NA 3rd, et al. Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2015 April 20. pii:ehv110. Epub ahead of print.
7.
Zurück zum Zitat Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296:1593–601.PubMedCrossRef Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296:1593–601.PubMedCrossRef
8.
Zurück zum Zitat Groeneweg JA, Heijden JF van der, Dooijes D, Veen TA van, Tintelen JP van, Hauer RA. Arrhythmogenic cardiomyopathy: diagnosis, genetic background, and risk management. Neth Heart J. 2014;22:316–25. doi:10.1007/s12471-014-0563-7.PubMedCentralPubMedCrossRef Groeneweg JA, Heijden JF van der, Dooijes D, Veen TA van, Tintelen JP van, Hauer RA. Arrhythmogenic cardiomyopathy: diagnosis, genetic background, and risk management. Neth Heart J. 2014;22:316–25. doi:10.1007/s12471-014-0563-7.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Steinvil A, Chundadze T, Zeltser D, et al. Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J Am Coll Cardiol. 2011;57:1291–6.PubMedCrossRef Steinvil A, Chundadze T, Zeltser D, et al. Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J Am Coll Cardiol. 2011;57:1291–6.PubMedCrossRef
10.
Zurück zum Zitat Lawless CE, Asplund C, Asif IM, et al. Protecting the heart of the American athlete: proceedings of the American College of Cardiology Sports and Exercise Cardiology Think Tank October 18, 2012, Washington, DC. J Am Coll Cardiol. 2014;64:2146–71. doi:10.1016/j.jacc.2014.08.027.PubMedCrossRef Lawless CE, Asplund C, Asif IM, et al. Protecting the heart of the American athlete: proceedings of the American College of Cardiology Sports and Exercise Cardiology Think Tank October 18, 2012, Washington, DC. J Am Coll Cardiol. 2014;64:2146–71. doi:10.1016/j.jacc.2014.08.027.PubMedCrossRef
11.
Zurück zum Zitat Corrado D, Pelliccia A, Bjornstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26:516–24.PubMedCrossRef Corrado D, Pelliccia A, Bjornstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26:516–24.PubMedCrossRef
12.
Zurück zum Zitat Leischik R, Dworrak B, Foshag P, et al. Pre-participation and follow-up screening of athletes for endurance sport. J Clin Med Res. 2015;7:385–92. doi:10.14740/jocmr2129w.PubMedCentralPubMedCrossRef Leischik R, Dworrak B, Foshag P, et al. Pre-participation and follow-up screening of athletes for endurance sport. J Clin Med Res. 2015;7:385–92. doi:10.14740/jocmr2129w.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Pickham D, Chan G, Carey M. Pre-participation screening for athletes and the role of advanced practice providers. J Electrocardiol. 2015;48:339–344. doi:10.1016/j.jelectrocard.2015.03.003.PubMedCrossRef Pickham D, Chan G, Carey M. Pre-participation screening for athletes and the role of advanced practice providers. J Electrocardiol. 2015;48:339–344. doi:10.1016/j.jelectrocard.2015.03.003.PubMedCrossRef
15.
Zurück zum Zitat Heidbuchel H, Papadakis M, Panhuyzen-Goedkoop N, et al. Position paper: proposal for a core curriculum for a European Sports Cardiology qualification. Eur J Prev Cardiol. 2013;20:889–903.PubMedCrossRef Heidbuchel H, Papadakis M, Panhuyzen-Goedkoop N, et al. Position paper: proposal for a core curriculum for a European Sports Cardiology qualification. Eur J Prev Cardiol. 2013;20:889–903.PubMedCrossRef
16.
Zurück zum Zitat Sande DA van de, Hoogeveen A, Hoogsteen J, Kemps HM. The diagnostic accuracy of exercise electrocardiography in asymptomatic recreational and competitive athletes. Scand J Med Sci Sports. 2015 Feb 3. doi:10.1111/sms.12420. Epub ahead of print. Sande DA van de, Hoogeveen A, Hoogsteen J, Kemps HM. The diagnostic accuracy of exercise electrocardiography in asymptomatic recreational and competitive athletes. Scand J Med Sci Sports. 2015 Feb 3. doi:10.1111/sms.12420. Epub ahead of print.
Metadaten
Titel
ECG screening in athletes: optional or mandatory?
verfasst von
E. E. van der Wall
Publikationsdatum
01.07.2015
Verlag
Bohn Stafleu van Loghum
Erschienen in
Netherlands Heart Journal / Ausgabe 7-8/2015
Print ISSN: 1568-5888
Elektronische ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-015-0724-3

Weitere Artikel der Ausgabe 7-8/2015

Netherlands Heart Journal 7-8/2015 Zur Ausgabe

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.